Psoriasis occurring after myeloablative therapy and autologous stem cell transplantation

Br J Dermatol. 2006 Jan;154(1):194-5. doi: 10.1111/j.1365-2133.2005.07026.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Humans
  • Lymphoma, Non-Hodgkin / immunology
  • Lymphoma, Non-Hodgkin / therapy*
  • Lymphoma, T-Cell / immunology
  • Lymphoma, T-Cell / therapy*
  • Male
  • Prednisone / administration & dosage
  • Psoriasis / etiology*
  • Psoriasis / immunology
  • Stem Cell Transplantation / adverse effects*
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol